The Business Group Blog was created to share and discuss information about challenges and solutions to the health care benefits issues that large employers face today and tomorrow — such as controlling health care costs, reforming the health care delivery system, and engaging employees in their health and benefits — and will provide insight into national health policy issues. We hope you find this information useful and will consider subscribing to the blog and sharing any thoughts or ideas with us at email@example.com.
While health care is not a top priority on the campaign trail and not top of voters’ minds this year, who wins on November 8 will impact the health care agenda in Washington in 2017. According to analysis presented in the Business Group’s special election year webinar earlier this week, even though Hillary Clinton and Donald Trump don’t offer many details about their health policy priorities, we can glean enough information from them and from Congress to make some predictions.
Are you struggling with managing specialty pharmacy in plan design? Our new Specialty Pharmacy Management Checklist provides detailed tips for staying ahead of the curve – from utilization management to reporting and accountability to employee education.
Here are some tips from the checklist:
Saturday, September 10, is World Suicide Prevention Day. The theme is Connect. Communicate. Care.
Over the last half century, suicide rates have increased by 60% in some areas of the world, particularly in developing countries. The causes of suicide are complex and varied. Risk factors include depression, substance abuse, previous suicide attempt(s), self-harm, abuse, violence, chronic pain, stressful life events and loss, as well as social, biological, environmental and cultural influences.
Simply adding new well-being programs at your organization is often not enough to increase the health and well-being of your employees. Often times, low engagement rates can become a barrier to creating a culture of well-being at your organization.
Controlling health benefits costs remains a high priority for large employers. While increases are expected to hold steady at 6% in 2017, costs are still running at more than twice the rate of inflation and general wage increases, thereby threatening affordability.
For the first time in 2010, the number of specialty drugs approved by the FDA surpassed that of traditional drugs, kick-starting a trend that we're continuing to see year after year. While only a small fraction (approx. 4%) of the patient population uses specialty medications, these costly drugs now account for 25% of total US drug spending and is the fastest growing cost in most employers' health benefits.